Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Form 8.3 - Plant Impact plc

19 Dec 2017 15:02

RNS Number : 8204Z
Nicholas Habgood
19 December 2017
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Mr. N. J. Habgood and family

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Plant Impact plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

19th December 2017

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

947,581

1.0%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

947,581

1.0%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

n/a

Details, including nature of the rights concerned and relevant percentages:

n/a

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

n/a

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

n/a

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

n/a

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

n/a

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

n/a

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19th December 2017

Contact name:

Nick Habgood

Telephone number:

02073193902

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETFFEFLUFWSEEE
Date   Source Headline
2nd Jul 200910:00 amRNSIssue of Equity
15th Jun 20097:00 amRNSPreliminary Final Results
12th Jun 200911:18 amRNSPlant Impact Announce R & D Collaboration
10th Jun 20097:00 amRNSPlant Impact Announce Validation of PiNT by USDA
1st Jun 20097:00 amRNSLicence Agreement
29th May 20097:00 amRNSTotal Voting Rights
21st May 200910:12 amRNSPlant Impact Announce Field Trial Results
18th May 20093:51 pmRNSExercise of Options
21st Apr 20098:00 amRNSSale of crop nutrient products
26th Mar 20093:33 pmRNSHolding(s) in Company
9th Mar 20097:00 amRNSField Trial Results
20th Feb 200910:00 amRNSLoan Agreement & Exclusive Discussions
13th Feb 20094:17 pmRNSHolding(s) in Company
13th Feb 20093:09 pmRNSHolding(s) in Company
13th Feb 200910:11 amRNSHolding(s) in Company
10th Feb 200912:29 pmRNSDirectorate Change
19th Jan 20092:10 pmRNSHolding(s) in Company
19th Jan 20092:10 pmRNSHolding(s) in Company
5th Jan 20094:24 pmRNSHolding(s) in Company
15th Dec 200810:23 amRNSHolding(s) in Company
9th Dec 20087:00 amRNSHalf Yearly Report
5th Sep 20081:58 pmRNSResult of AGM
3rd Sep 20082:41 pmRNSDirectorate Change
1st Sep 20085:22 pmRNSDirector Declaration
20th Aug 20087:01 amRNSAnnual Report and Accounts
20th Aug 20087:00 amRNSBugoil - submission of regist
11th Aug 20087:00 amRNSNotice of AGM
29th Jul 20082:30 pmRNSHolding(s) in Company
10th Jul 20082:14 pmRNSHolding(s) in Company
23rd Jun 20087:00 amRNSFinal Results
9th Jun 20083:08 pmRNSReplacement -Notice of Result
9th Jun 20087:00 amRNSNotice of Results
12th May 20086:00 amRNSDistribution Agreement
14th Apr 20087:00 amRNSUS Agreement Signed
10th Mar 20087:00 amRNSBugOil Trial Results Update
22nd Feb 20087:00 amRNSHolding(s) in Company
21st Feb 20087:00 amRNSPlacing
11th Dec 20074:26 pmRNSHolding(s) in Company
11th Dec 20074:22 pmRNSHolding(s) in Company
26th Nov 20077:00 amRNSInterim Results
16th Nov 200710:00 amRNSNotice of Results
1st Nov 20077:02 amRNSAnalyst and media site visit
30th Oct 20077:01 amRNSGrape field trial results
8th Oct 20077:01 amRNSSuccessful field trial result
27th Sep 20077:01 amRNSSuccessful field trial result
5th Sep 200711:44 amRNSResult of AGM
21st Aug 200711:08 amRNSAppointment of Joint Broker
17th Aug 20079:46 amRNSAIM Rule 26 Information
2nd Jul 200711:09 amRNSFinal Results 31 March 2007
2nd Jul 20077:01 amRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.